BeOne Medicines AG (SHA:688235)
232.89
-5.60 (-2.35%)
Mar 9, 2026, 3:00 PM CST
BeOne Medicines AG Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 230,393 | 235,145 | 143,553 | 133,746 | 157,552 | 176,878 | Upgrade
|
| Market Cap Growth | 21.86% | 63.80% | 7.33% | -15.11% | -10.93% | 15.32% | Upgrade
|
| Enterprise Value | 206,567 | 214,043 | 131,421 | 116,580 | 127,415 | 156,439 | Upgrade
|
| Last Close Price | 232.89 | 268.60 | 161.02 | 139.04 | 132.45 | 144.51 | Upgrade
|
| PE Ratio | 114.80 | 117.17 | - | - | - | - | Upgrade
|
| PS Ratio | 6.16 | 6.29 | 5.16 | 7.67 | 16.13 | 23.67 | Upgrade
|
| PB Ratio | 7.55 | 7.71 | 5.90 | 5.33 | 5.21 | 4.54 | Upgrade
|
| P/TBV Ratio | 7.66 | 7.82 | 5.99 | 5.42 | 5.26 | 4.58 | Upgrade
|
| P/FCF Ratio | 34.98 | 35.70 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 29.21 | 29.82 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 5.61 | 5.73 | 4.72 | 6.69 | 13.05 | 20.94 | Upgrade
|
| EV/EBITDA Ratio | 50.36 | 52.87 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 69.31 | 68.44 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | 31.36 | 32.49 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.25 | 0.32 | 0.26 | 0.14 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 1.79 | 1.79 | - | - | - | - | Upgrade
|
| Debt / FCF Ratio | 1.16 | 1.16 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.79 | -0.79 | -0.46 | -0.63 | -0.90 | -0.97 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.97 | -5.97 | 3.86 | 2.00 | 2.28 | 4.25 | Upgrade
|
| Net Debt / FCF Ratio | -3.67 | -3.67 | 2.44 | 1.30 | 2.16 | 3.80 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.65 | 0.40 | 0.19 | 0.17 | Upgrade
|
| Inventory Turnover | 1.21 | 1.21 | 1.30 | 1.09 | 1.09 | 0.99 | Upgrade
|
| Quick Ratio | 2.97 | 2.97 | 1.51 | 1.97 | 3.22 | 4.45 | Upgrade
|
| Current Ratio | 3.41 | 3.41 | 1.80 | 2.32 | 3.55 | 4.76 | Upgrade
|
| Return on Equity (ROE) | 7.46% | 7.46% | -18.77% | -22.26% | -38.11% | -29.15% | Upgrade
|
| Return on Assets (ROA) | 3.96% | 3.96% | -6.06% | -12.39% | -15.00% | -12.72% | Upgrade
|
| Return on Invested Capital (ROIC) | 30.49% | 22.87% | -36.89% | -138.75% | -549.14% | - | Upgrade
|
| Return on Capital Employed (ROCE) | 7.00% | 7.00% | -15.30% | -30.20% | -36.40% | -20.70% | Upgrade
|
| Earnings Yield | 0.87% | 0.85% | -3.28% | -4.67% | -8.77% | -5.24% | Upgrade
|
| FCF Yield | 2.86% | 2.80% | -3.22% | -9.12% | -7.98% | -5.61% | Upgrade
|
| Buyback Yield / Dilution | -7.75% | -7.75% | -0.86% | -1.22% | -11.15% | -11.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.